ASBP
Aspire Biopharma
ASBP
ASBP
12 hedge funds and large institutions have $372K invested in Aspire Biopharma in 2026 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
12
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$228K | |
| 2 | +$137K | |
| 3 | +$66K | |
| 4 |
CA
Crossingbridge Advisors
Pleasantville,
New York
|
+$42.2K |
| 5 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
+$8.89K |
Top Sellers
| 1 | -$90.8K | |
| 2 | -$47.1K | |
| 3 | -$35K | |
| 4 |
PA
Procyon Advisors
Shelton,
Connecticut
|
-$30.7K |
| 5 |
RA
Resolute Advisors
San Francisco,
California
|
-$20.6K |
